{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"7.69"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"13"}],"units":"Participants"}],"description":"Death in a patient after transplant due to protocol treatment is defined as an TRM.","groups":[{"description":"Conventional bone marrow transplant (BM)","id":"OG000","title":"Control BM Arm"},{"description":"G-CSF (filgrastim) stimulated bone marrow (G-BM)","id":"OG001","title":"Experimental G-BM Arm"}],"paramType":"NUMBER","populationDescription":"One patient is inevaluable and is excluded from analysis.","reportingStatus":"POSTED","timeFrame":"100 days","title":"Estimated 100-day Transplant Related Mortality (TRM) Percentage","type":"SECONDARY","unitOfMeasure":"percentage of patients"}